Protagonist Therapeutics, Inc.PTGXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank91
3Y CAGR+0.7%
5Y CAGR+1.8%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+0.7%/yr
vs +11.2%/yr prior
5Y CAGR
+1.8%/yr
Consistent
Acceleration
-10.5pp
Decelerating
Percentile
P91
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $128.39M | +32.0% |
| 2024 | $97.25M | -47.9% |
| 2023 | $186.73M | +48.5% |
| 2022 | $125.74M | +1.7% |
| 2021 | $123.67M | +5.4% |
| 2020 | $117.36M | +255.6% |
| 2019 | $33.01M | -59.9% |
| 2018 | $82.23M | -22.4% |
| 2017 | $106.03M | +402.9% |
| 2016 | $21.08M | - |